Publications by authors named "Ryan Sides"

Claim this Profile
A
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.
Angelo Camporeale, David Kudrow, Ryan Sides, Shufang Wang, Annelies Van Dycke

BMC Neurol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
Virginia L Stauffer, Ryan Sides, Michel Lanteri-Minet, William Kielbasa, Yan Jin

Patient Prefer Adherence· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis